We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology

Acquirer Target Price
Mereo BioPharma Group Ltd. License to AZD9668 $5 million
Vaxart, Inc. Aviragen Therapeutics, Inc. $60 million
Synthetic Genomics, Inc. Collaboration on RNA-based vaccines N/A
Sarepta Therapeutics License to CRISPR/Cas9 technology N/A
Mallinckrodt plc Ocera Therapeutics, Inc. $48.9 million
Boehringer Ingelheim Collaboration on GalXC™ RNAi therapeutics $200 million
AstraZeneca plc Collaboration on AZD7970 N/A
ADCendo ApS License to uPARAP receptor drugs N/A

eHealth

Acquirer Target Price
Revint Solutions Health Check N/A
New Mountain Capital, LLC Cytel, Inc. N/A

Laboratories, MRI and Dialysis

Acquirer Target Price
Quest Diagnostics Inc. California Laboratory Associates N/A

Long-Term Care

Acquirer Target Price
Accura HealthCare 6 skilled nursing facilities N/A
CareTrust REIT, Inc. 3 skilled nursing facilities $69 million
Kandu Capital, LLC Osprey Health Care Center $5.55 million
Private equity fund 2 Senior Living Communities N/A
Not disclosed Skilled Nursing Facility N/A
Regional Owner/Operator Illinois Knights Templar Home $1.95 million
Focus Healthcare Partners LLC Bartlett Reserve $15.8 million
Noland Health Services, Inc. Fairhope Nursing $6 million
SHA Capital Partners Clifden Court N/A

Managed Care

Acquirer Target Price
McLaren Health Care MDwise N/A

Medical Devices

Acquirer Target Price
The Jordan Company Young Innovations, Inc. N/A
HealthEdge Investment Partners, LLC Westone Laboratories, Inc. N/A
Medline Industries, Inc. Centurion Medical Products N/A

Pharmaceuticals

Acquirer Target Price
Novartis Advanced Accelerator Applications S.A. $3.9 billion
PMC YM-Pharma Private Ltd. Yegna Manojavam Drugs and Chemicals Ltd N/A
Medicure Inc. License to PREXXARTAN® N/A
Torrent Pharmaceuticals, Ltd. Unichem Labs’ India business $558 million

Physician Medical Groups

Acquirer Target Price
Prelude Fertility Inc. Vivere Health, LLC N/A
Aurora Diagnostics LLC CytoPath N/A
Platinum Dermatology Partners Howsden Dermatology N/A
Epiphany Dermatology Academy Dermatologists Group, LLC N/A

Rehabilitation

Acquirer Target Price
U.S. HealthWorks Workforce Health of South Bend N/A
U.S. Physical Therapy, Inc. 9 clinic physical therapy practice $4.5 million

Other Services

Acquirer Target Price
New MainStream Capital GrapeTree Medical Staffing N/A
Concept Life Sciences Aquila BioMedical N/A
Owens & Minor, Inc. Halyard Health’s surgical and infection prevention business $710 million
CiToxLAB Group Xenometrics N/A
Sterigenics International LLC Toxikon Europe N.V. N/A
PharmScript ContinuaRx N/A
DentaQuest Access Dental Plan, LLC N/A